Interleukin Genetics Inc

(NASDAQ:ILI)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 5,915 7,066 4,472 7,646
Restricted Cash — — — —
Marketable Securities — — — —
Accounts Receivable 791 1,215 1,246 990
Loans Receivable — — — —
Other Receivable — — — —
Receivables 791 1,215 1,246 990
Raw Materials 130 131 124 93
Work in Progress — — — —
Purchased Components — — — —
Finished Goods 701 847 877 906
Other Inventories — — — —
Inventories Adjustments and Allowances — — — —
Inventories 831 978 1,001 999
Prepaid Expenses 264 347 388 335
Current Deferred Income Taxes 57 50 50 41
Other Current Assets — — — —
Total Current Assets 7,859 9,657 7,159 10,013
Land and Improvements — — — —
Building and Improvements — — — 266
Machinery Furniture and Equipment — — — 1,400
Construction in Progress — — — —
Other Fixed Assets 1,766 1,757 1,815 213
Total Fixed Assets 1,766 1,757 1,815 1,878
Gross Fixed Assets 1,766 1,757 1,815 1,878
Accumulated Depreciation and Depletion 1,299 1,299 1,299 1,299
Net Fixed Assets 467 458 516 579
Intangibles 4,967 5,194 5,470 5,741
Cost in Excess — — — —
Non Current Deferred Income Taxes — — — —
Other Non Current Assets 53 53 53 53
Total Non Current Assets 5,487 5,706 6,040 6,373
Total Assets 13,346 15,362 13,198 16,386
Liabilities
Current Liabilities
Accounts Payable 638 853 1,186 836
Notes Payable — — — —
Short Term Debt — — 595 595
Accrued Expenses 1,994 1,981 1,720 1,948
Accrued Liabilities — — — —
Deferred Revenues 781 951 1,053 1,458
Current Deferred Income Tax Liabilities — — — —
Other Current Liabilities 22 35 82 1,325
Total Current Liabilities 3,436 3,820 4,636 6,163
Non Current Liabilities
Long Term Debt 4,000 4,000 — —
Capital Lease Obligations — — — —
Deferred Income Tax Liabilities — 37 37 31
Other Non Current Liabilities — — — —
Minority Interest Liabilities — — — —
Preferred Securities of Subsidiary Trust Liabilities — — — —
Preferred Equity Outside Stock Equity — — — —
Total Non Current Liabilities 7,436 7,857 4,673 6,194
Total Liabilities 4,000 4,037 37 31
Shareholders' Equity
Preferred Stock Equity 5 5 5 5
Common Stock Equity 5,905 7,501 8,521 10,187
Common Par 32 32 31 31
Additional Paid in Capital 85,418 85,372 84,726 84,518
Cumulative Translation Adjustment — — — —
Retained Earnings -79,545 -77,903 -76,236 -74,361
Treasury Stock — — — —
Other Equity Adjustments — — — —
Total Capitalization 9,910 11,506 8,526 10,192
Cash Flow -4,841 -4,098 -4,193 -3,778
Working Capital 4,423 5,837 2,523 3,850
Free Cash Flow -5,522 -3,875 -3,116 -2,640
Invested Capital 9,910 11,506 8,526 10,192
Total Equity 5,910 7,506 8,526 10,192
Total Liabilities and Stock Equity 13,346 15,362 13,198 16,386